Email Us Here

New Addition to the Prostate Cancer Roundtable Policy Agenda Addresses Quality-of-Life Endpoints

The Prostate Cancer Roundtable has updated its shared national policy agenda for 2014 to include a new policy priority, that Phase III clinical trials of new drugs and treatment be evaluated for their impact on patient-reported quality of life.